Retraction of: Quiescent very small embryonic-like stem cells resist oncotherapy and can restore spermatogenesis in germ cell depleted mammalian testis.

Abstract

Stem Cells and DevelopmentVol. 23, No. 12 RetractionFree AccessRetraction of: Quiescent Very Small Embryonic-Like Stem Cells Resist Oncotherapy and Can Restore Spermatogenesis in Germ Cell Depleted Mammalian TestisSandhya Anand, Deepa Bhartiya, Kalpana Sriraman, Hiren Patel, Dhananjay Manjramkar, Ganesh Bakshi, Vandana Dhamankar, and Purna KurkureSandhya AnandSearch for more papers by this author, Deepa BhartiyaSearch for more papers by this author, Kalpana SriramanSearch for more papers by this author, Hiren PatelSearch for more papers by this author, Dhananjay ManjramkarSearch for more papers by this author, Ganesh BakshiSearch for more papers by this author, Vandana DhamankarSearch for more papers by this author, and Purna KurkureSearch for more papers by this authorPublished Online:5 Jun 2014https://doi.org/10.1089/scd.2013.0059.retractAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail The authors of the article entitled, “Quiescent Very Small Embryonic-Like Stem Cells Resist Oncotherapy and Can Restore Spermatogenesis in Germ Cell Depleted Mammalian Testis (DOI: 10.1089/scd.2013.0059; PMID: 24079711)” which was published in Stem Cells and Development online ahead of print in its unedited format but not yet included in a full issue, have requested a retraction of the article.The study comprised of animal and human studies. Mouse studies showed that pluripotent VSELs in testis are protected from busulphan treatment and can restore spermatogenesis if healthy somatic (sertoli or mesenchymal) cells are transplanted. This study was approved by Animal Ethics Committee at National Institute for Research in Reproductive Health (NIRRH).The human part of the study involved demonstration of similar pluripotent stem cells in testicular biopsy of seven adult azoospermic survivors of various kinds of childhood cancer.This study was approved by Institutional Committee for Stem Cells Research and Therapy (ICSCRT) at NIRRH and by Institute Ethics Committee of Tata Memorial Hospital (TMH). Biopsies were collected after proper informed consent of the study participants following all principles of bioethics and approvals at TMH. However, the authors have discovered they have erred and did not obtain approval from NIRRH Ethics Committee which was mandatory prior to handling the clinical samples.All authors listed on the paper were contacted by Graham Parker, PhD, the Editor-in-Chief of Stem Cells and Development, to ensure their agreement to this retraction. All authors have agreed to the retraction, except Drs. Bakshi and Kurkure who have refused to communicate their agreement with the retraction.Stem Cells and Development is committed to the highest standards of scientific excellence in peer review, and supports the authors' request to retract the article.FiguresReferencesRelatedDetailsCited byActivation of MT1/MT2 to Protect Testes and Leydig Cells against Cisplatin-Induced Oxidative Stress through the SIRT1/Nrf2 Signaling Pathway19 May 2022 | Cells, Vol. 11, No. 10Stem Cells in Regenerative Therapy9 September 2014 Volume 23Issue 12Jun 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Sandhya Anand, Deepa Bhartiya, Kalpana Sriraman, Hiren Patel, Dhananjay Manjramkar, Ganesh Bakshi, Vandana Dhamankar, and Purna Kurkure.Retraction of: Quiescent Very Small Embryonic-Like Stem Cells Resist Oncotherapy and Can Restore Spermatogenesis in Germ Cell Depleted Mammalian Testis.Stem Cells and Development.Jun 2014.1428-1428.http://doi.org/10.1089/scd.2013.0059.retractPublished in Volume: 23 Issue 12: June 5, 2014PDF download